Document is current
Any future updates will be listed below
-
Authors
Moser, Tobias https://orcid.org/0000-0001-7145-0533
Chen, Han https://orcid.org/0009-0003-1357-5161
Kusch, Kathrin
Behr, Rüdiger https://orcid.org/0000-0001-8816-6619
Vona, Barbara https://orcid.org/0000-0002-6719-3447
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC 2067/1- 390729940)
Deutsche Forschungsgemeinschaft (MO896/5)
Deutsche Forschungsgemeinschaft (VO 2138/7‐1)
Fondation Pour l'Audition (FPA RD-2020-10)
Max-Planck-Gesellschaft (Max-Planck-Fellowship)
- License Information
-
More Information
Article History
Received: 19 February 2024
Revised: 22 February 2024
Accepted: 11 March 2024
First Online: 25 March 2024
Disclosure and competing interests statement
: Tobias Moser is co-founder of OptoGenTech company that aims to develop optogenetic hearing restoration. The remaining authors declare no competing interests.
